Custom formulations of popular weight loss medications have surged in popularity due to the high costs of FDA-approved drugs.

Strive Compounding Pharmacy sues Eli Lilly and Novo Nordisk over alleged GLP-1 weight loss drug competition limits. Read more here.

A consumer pricing framework for 'Cheapest Compounded Semaglutide,' 'Cheapest Compounded Semaglutide Online,' and 'Cheapest ...

As a youth activist in Colorado, I’ve spent years organizing around the issues that shape our generation’s lives — and across ...

In spring 2025, the Food and Drug Administration (FDA) resolved and ended the GLP-1 medications shortage, subsequently releasing declaratory orders that neither outsourcing compounding pharmacies or ...

Are compounded GLP-1s for weight loss safe? GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably heard of them under brand ...

The Food and Drug Administration (FDA) recently declared an end to the shortage of semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), categorized broadly as GLP-1 weight loss ...

Strive Specialities Inc., a major provider of compounded medicines, filed a federal lawsuit against pharmaceutical giants Eli ...

By Maggie Fick and Mrinalika Roy Jan 12 (Reuters) - Novo Nordisk CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using compounded versions of blockbuster GLP-1 ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight.

COLORADO SPRINGS — Maybe you’ve heard of someone taking GLP-1s, or you’ve seen celebrities like Serena Williams talk about taking them for weight loss. Over the past few years, it’s been sold to ...